Clinical Research Directory

Bioequivalence Study Between YHP2508B and YHR2602 in Healthy Subjects

Sponsor: Yuhan Corporation

Summary

An open-label, randomized, fasting, single-dose, oral administration, 2-sequence, 4-period, replicate crossover study to evaluate bioequivalence between YHP2508B and YHR2602 in healthy subjects.

Official title: An Open-label, Randomized, Fasting, Single-dose, Oral Administration, 2-sequence, 4-period, Replicate Crossover Study to Evaluate Bioequivalence Between YHP2508B and YHR2602 in Healthy Subjects

Key Details

Conditions

Interventions

Locations (1)